Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Sep;74(3):224–228. doi: 10.1136/hrt.74.3.224

Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.

D Ketley 1, K L Woods 1
PMCID: PMC484010  PMID: 7547014

Abstract

OBJECTIVES--To identify and rank the factors that currently limit the use of thrombolytic treatment in patients admitted to hospital with acute myocardial infarction. DESIGN--Weighted sampling study with retrospective data retrieval from clinical records. SETTING--All hospitals within the Trent region providing acute general medical services. PATIENTS--Random sample of 420 patients admitted during February-April 1993 who had acute myocardial infarction as the main discharge diagnosis. MAIN OUTCOME MEASURES--Treatment odds ratios (and 95% confidence intervals (CI)) for the use of thrombolysis in patient groups defined by relevant clinical characteristics. RESULTS--The patient population was older and less likely to have ST segment elevation on the initial electrocardiogram than patients entered into the randomised trials of thrombolysis. Thrombolytic treatment was given to 49% of patients (SE 2.4%). After controlling for negative associations with a history of stroke (treatment odds ratio 0.18 (95% CI 0.04 to 0.53)) and peptic ulcer (odds ratio 0.52 (95% CI 0.26 to 1.01)) use of thrombolysis decreased with increasing patient age. This was particularly noticeable for those aged > 74 years (odds ratio 0.17 (95% CI 0.05 to 0.51)) relative to those aged < 65 years. Thrombolysis was less likely to be used in patients with ST depression (odds ratio 0.22 (95% CI 0.11 to 0.41)) or bundle branch block (odds ratio 0.18 (95% CI 0.07 to 0.44)) than in those with ST elevation on the initial electrocardiogram. Delay from symptom onset to admission was more than 12 h in 15% of patients. CONCLUSIONS--The patient population admitted to hospital with acute myocardial infarction differs in several respects from the samples that have been included in the trials of thrombolysis. The main factors limiting wider use of thrombolysis are diagnostic uncertainty at admission and delayed presentation. Perceived clinical contraindications to treatment are of lesser importance. There is evident reluctance to use thrombolytic treatment in older patients, who were substantially under-represented in the clinical trials.

Full text

PDF
224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J., Trent R., Rawles J. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group. BMJ. 1993 Aug 14;307(6901):409–413. doi: 10.1136/bmj.307.6901.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Birkhead J. S. Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London. BMJ. 1992 Aug 22;305(6851):445–448. doi: 10.1136/bmj.305.6851.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarke K. W., Gray D., Keating N. A., Hampton J. R. Do women with acute myocardial infarction receive the same treatment as men? BMJ. 1994 Sep 3;309(6954):563–566. doi: 10.1136/bmj.309.6954.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Elder A. T., Fox K. A. Thrombolytic treatment for elderly patients. BMJ. 1992 Oct 10;305(6858):846–847. doi: 10.1136/bmj.305.6858.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Every N. R., Larson E. B., Litwin P. E., Maynard C., Fihn S. D., Eisenberg M. S., Hallstrom A. P., Martin J. S., Weaver W. D. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med. 1993 Aug 19;329(8):546–551. doi: 10.1056/NEJM199308193290807. [DOI] [PubMed] [Google Scholar]
  6. Haigh R., Castleden M., Woods K., Fletcher S., Bowns I., Gibson M., Soper J. Management of myocardial infarction in the elderly: admission and outcome on a coronary care unit. Health Trends. 1991;23(4):154–157. [PubMed] [Google Scholar]
  7. Hamm C. W. New serum markers for acute myocardial infarction. N Engl J Med. 1994 Sep 1;331(9):607–608. doi: 10.1056/NEJM199409013310910. [DOI] [PubMed] [Google Scholar]
  8. Hannaford P. C., Kay C. R., Ferry S. Agism as explanation for sexism in provision of thrombolysis. BMJ. 1994 Sep 3;309(6954):573–573. doi: 10.1136/bmj.309.6954.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ketley D., Woods K. L. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 1993 Oct 9;342(8876):891–894. doi: 10.1016/0140-6736(93)91945-i. [DOI] [PubMed] [Google Scholar]
  10. Rawles J. Deciding who should have thrombolysis. BMJ. 1994 Jan 1;308(6920):59–60. doi: 10.1136/bmj.308.6920.59a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Simoons M. L., Maggioni A. P., Knatterud G., Leimberger J. D., de Jaegere P., van Domburg R., Boersma E., Franzosi M. G., Califf R., Schröder R. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993 Dec 18;342(8886-8887):1523–1528. doi: 10.1016/s0140-6736(05)80089-3. [DOI] [PubMed] [Google Scholar]
  12. Weston C. F., Penny W. J., Julian D. G. Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group. BMJ. 1994 Mar 19;308(6931):767–771. doi: 10.1136/bmj.308.6931.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]
  14. Wilkinson P., Laji K., Ranjadayalan K., Parsons L., Timmis A. D. Acute myocardial infarction in women: survival analysis in first six months. BMJ. 1994 Sep 3;309(6954):566–569. doi: 10.1136/bmj.309.6954.566. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES